(Q40230314)

18 September 2017

title

Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis (English)

1 reference

18 September 2017

1 reference

1 reference

Liu B

1

1 reference

18 September 2017

Lee KW

2

1 reference

18 September 2017

Anzo M

3

1 reference

18 September 2017

Zhang B

4

1 reference

18 September 2017

Zi X

5

1 reference

18 September 2017

Tao Y

6

1 reference

18 September 2017

Shiry L

7

1 reference

18 September 2017

Pollak M

8

1 reference

18 September 2017

Lin S

9

1 reference

18 September 2017

Cohen P

10

1 reference

18 September 2017

language of work or name

English

0 references

publication date

18 September 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

26

1 reference

18 September 2017

issue

12

1 reference

18 September 2017

page(s)

1811-1819

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209977

18 September 2017

exact match

0 references

cites work

Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Expression of insulin-like growth factor binding protein (IGFBP)-3, and the effects of IGFBP-2 and -3 in the bovine corpus luteum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Vascular endothelial growth factor C induces angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Targeting hypoxia and angiogenesis through HIF-1alpha inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Insulin-like growth factor (IGF) signalling is required for early dorso-anterior development of the zebrafish embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Cellular actions of the insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Endogenous angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Development of strategies for the use of anti-growth factor treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Insulin-like Growth Factor 1 Binding Protein 3 Synthesis by Aortic Endothelial Cells Is a Function of Cell Density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Microvessel density in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Vascular endothelial growth factor and transforming growth factor-beta1 regulate the expression of insulin-like growth factor-binding protein-3, -4, and -5 in large vessel endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Role of vascular endothelial growth factor in regulation of physiological angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Changes in insulin-like growth factor-binding protein-3 messenger ribonucleic acid in endothelial cells of the human corpus luteum: a possible role in luteal development and rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Insulin-like growth factor binding protein-3 mRNA expression in endothelial cells of the primate corpus luteum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Perinatal hypoxia-ischemia decreased neuronal but increased cerebral vascular endothelial IGFBP3 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209977

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209977

1 reference

Dimensions Publication ID

18 September 2017

1042760712

0 references

Fatcat ID

release_tbwz565u2rfs7pprtlzb46qqbe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tbwz565u2rfs7pprtlzb46qqbe

24 November 2022

mapped directly with Wikidata item

1 reference